Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

144 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-06-30

Study Completion Date

2011-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine that ibuprofen 50mg/g gel is effective and safety treating patients with muscle aches, joint pains or due to sprains, bruises, tendinitis or myofascial compared to Profenid 25mg/g gel.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety Study of Ibuprofen Gel Compared to Placebo in the Treatment of Acute Musculoskeletal Pain

NCT05013567

Musculoskeletal Pain Acute Pain Stretch +1 more

UNKNOWN PHASE3

Topical Ibuprofen for Delayed Onset Mulscle Soreness

NCT01794923

Pain

COMPLETED PHASE3

5% Topical Ibuprofen (IBU) for Ankle Sprain

NCT01945034

Ankle Injuries

COMPLETED PHASE3

A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness

NCT02113566

Delayed Onset Muscle Soreness

COMPLETED PHASE4

Ibuprofen Versus Placebo For Muscle Soreness

NCT03228992

Muscle Soreness

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective of this study is to evaluate the efficacy of ibuprofen 50 mg/g gel in the treatment of patients with muscle, joint pain caused by sprains, contusions, tendinitis, or myofascial compared to Profenid 25mg/g gel.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscular Atrophy Sprains Tendonitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Profenid

Apply the gel on the spot of pain or injury, massaging slightly to facilitate the penetration of 8 in 8 hours during 5 days. Leave the gel on the the site at least 4 hours before removal

Group Type ACTIVE_COMPARATOR

Profenid

Intervention Type DRUG

Apply the gel on the spot of pain or injury, massaging slightly to facilitate the penetration of 8 in 8 hours during 5 days. Leave the gel on the the site at least 4 hours before removal

Ibuprofen

Apply the gel on the spot of pain or injury, massaging slightly to facilitate the penetration of 8 in 8 hours during 5 days. Leave the gel on the the site at least 4 hours before removal

Group Type ACTIVE_COMPARATOR

Ibuprofen

Intervention Type DRUG

Apply the gel at the site of pain or injury, massaging gently to promote penetration of 8 in 8 hours for 5 days. Leave the gel on the premises at least 4 hours before removal

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ibuprofen

Apply the gel at the site of pain or injury, massaging gently to promote penetration of 8 in 8 hours for 5 days. Leave the gel on the premises at least 4 hours before removal

Intervention Type DRUG

Profenid

Apply the gel on the spot of pain or injury, massaging slightly to facilitate the penetration of 8 in 8 hours during 5 days. Leave the gel on the the site at least 4 hours before removal

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of both sexes, of any race, aged 12 years;
* Ability to read, understand and sign the Informed Consent in the case of minors monitoring and consent of a parent;
* Complaint of clinical muscle pain, joint pain caused by sprains, contusions, tendonitis, or myofascial;
* Score more than 4 VAS symptom reviewed: Pain;
* Patients able to understand and follow the protocol of the trial.
* Patients with or without ligament injury ligament injury partial and incomplete

Exclusion Criteria

* Known hypersensitivity to components of the formula, both the medication and the comparative test;
* Hypersensitivity to acetylsalicylic acid;
* Hypersensitivity to ketoprofen, ibuprofen or other anti-inflammatory steroid;
* Hypersensitivity to acetaminophen;
* Skin changes in the pathological site of application, such as eczema or acne, or infected skin or wound;
* Pregnant or lactating women.
* Patients who require surgery or immobilization;
* Patients with fractures or ligament rupture;
* Patients taking anticoagulants;
* Patients with decompensated concomitant systemic diseases, such as diabetes, congenital or acquired blood disorders, convulsive disorders, autoimmune diseases, renal failure, severe infections, hormonal disorders and pulmonary disorders;
* Use of NSAIDs, corticosteroids or venotherapics, threads or any other form of administration;
* History of alcoholism or substance abuse;
* Conditions in the opinion of the investigator make the patient unsuitable to participate in the study.

Minimum Eligible Age

12 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No